About Bluefish Pharmaceuticals Private Limited
Data last updated:
Bluefish Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Bluefish Pharmaceuticals Ab Sweden. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U02423KA2006PTC049950. Its GSTIN is 29AACCB9703E1ZR (Karnataka).
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹2.4 Cr. It is led by directors Vivekanandan Sundaramurthy and Astha Sehgal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.17 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.76 Cr (net margin 7.3%) and EBITDA of ₹2.85 Cr (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
The company has about 81 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bluefish Pharmaceuticals. Court records list 1 case involving the company, including 1 filed by the company. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.42 Cr; the latest was in October 2017.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bluefishpharma.com.
Company details
CIN history
Bluefish Pharmaceuticals has one previous CIN (Corporate Identification Number): U02423TN2006PTC061230. The current CIN is U02423KA2006PTC049950, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U02423KA2006PTC049950 | Current |
| U02423TN2006PTC061230 | Previous |
Contact details
Bluefish Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is bluefishpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGlobal Technology & Development Cent Bgr Triangle 3 3rd Fl Einstein Bldg. Sy No 63/3B Gor, Vigere Vil, Bangalore, Karnataka, India – 560067
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bluefish Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bluefish Pharmaceuticals operates one associated brand: Bluefish Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Bioequivalent generic pharmaceuticals are developed and manufactured affordably. | bluefishpharma.com |
Business activity
The main business activities of Bluefish Pharmaceuticals are support service to organizations and professional, scientific and technical. In detail, this covers other support services to organizations and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Bluefish Pharmaceuticals Private Limited, buy the company report.
Financials of Bluefish Pharmaceuticals Private Limited
FY 2025 filings availableBluefish Pharmaceuticals Private Limited reported revenue of ₹24.17 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.76 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bluefish Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bluefish Pharmaceuticals Private Limited
Bluefish Pharmaceuticals has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivekanandan Sundaramurthy | Director | 23 Aug 2021 | 5 Years 2 Months | Current |
| Astha Sehgal | Director | 19 Nov 2021 | 4 Years 11 Months | Current |
Auditor
Bluefish Pharmaceuticals Private Limited is audited by N J SURESH & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N J SURESH & ASSOCIATES | FY 2022 | 010449S |
Shareholding
The shareholding of Bluefish Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bluefish Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Bluefish Pharmaceuticals Private Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.42 Cr; the latest was in October 2017.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2017 | Secondary share transfer | Undisclosed | Buyer: Bluefish Pharmaceuticals AB & Yogesh Kota Seller: Bluefish Pharmaceuticals AB & Umamaheshwari T N |
| Dec 2014 | Rights issue | ₹3.05 Cr | Investors: Bluefish Pharmaceuticals AB |
| Mar 2014 | Funding round | ₹7.02 Cr | Investors: Bluefish Pharmaceuticals AB |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: Bluefish Pharmaceuticals AB & Umamaheshwari T N Seller: Bluefish Pharmaceuticals AB & S Nanda Kumar |
| Dec 2010 | Funding round | ₹40 Lakh | Investors: Bluefish Pharmaceuticals AB |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bluefish Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Bluefish Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against The Union of India and 3 others | Disposed |
To see the full case history of Bluefish Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bluefish Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bluefish Pharmaceuticals Private Limited has a workforce of 81 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Bluefish Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB9703E1ZR | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bluefish Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bluefish Pharmaceuticals Private Limited has 15 board changes on record since 2007: 3 appointments and 12 cessations. The latest: Astha Sehgal ceased to be Additional Director on 30 Sep 2022.
6 earlier events are in the company report.
Frequently asked questions
Bluefish Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 September 2006 (20+ years old) and is registered under CIN U02423KA2006PTC049950.
Bluefish Pharmaceuticals has 2 current directors:
- Vivekanandan Sundaramurthy - Director
- Astha Sehgal - Director
The latest financial statements of Bluefish Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bluefish Pharmaceuticals is 29AACCB9703E1ZR, registered in Karnataka.
The CIN (Corporate Identification Number) of Bluefish Pharmaceuticals is U02423KA2006PTC049950. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bluefish Pharmaceuticals has 1 court case on record: 1 filed by the company.
Bluefish Pharmaceuticals was incorporated on 28 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
Bluefish Pharmaceuticals has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.42 Cr; the latest was in October 2017.
Astha Sehgal ceased to be Additional Director on 30 Sep 2022. Erik Olof Ekman ceased to be Additional Director on 30 Sep 2022. Erik Olof Ekman was appointed as Director on 07 Sep 2022. Bluefish Pharmaceuticals has 15 board changes on record in total.
Bluefish Pharmaceuticals can be reached through the website bluefishpharma.com. Its registered office is in Bangalore, Karnataka, India.